Takeda Press Releases

Read the latest headlines regarding our products, pipeline and community involvement.

TAP Press Releases

Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. merged on July 1, 2008 with TAP Pharmaceutical Products Inc. (TAP), forming one of the top 15 pharmaceutical companies in the United States.

The merger is a result of the conclusion of a 30-year joint venture between Takeda Pharmaceutical Company Limited and Abbott announced May 1, 2008. According to terms previously announced, Takeda received the rights to TAP’s product Prevacid^®, its non-Lupron related commercial organization, TAP's support organizations, and TAP’s pipeline.

• May 18, 2008
  TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
• March 26, 2008
  Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
• January 3, 2008
  TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders

Please click here to view Important Safety Information and Prescribing Information about Takeda's products.